GNIPST BULLETIN 2015

16-10-2015

National Seminer on Current Innovation in Biotechnology for Human Welfare, 7th November, 2015 at GNIPST

16th October, 2015

Volume No.: 50

Issue No.: 01

Vision
TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE
FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE
BASED LEARNING AND PRACTICE

Contents

Message from PRINCIPAL

Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking
News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive

GNIPST Photo Gallery

For your comments/contribution

OR For Back-Issues,
mailto:gnipstbulletin@gmail.com
GURU NANAK INSTITUTE OF PHARMACEUTICAL
SCIENCE AND TECHNOLOGY
Website: http://gnipst.ac.in

16-10-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.
Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.
I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.
It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.
The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.
The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.
I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.
Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.
My best wishes to all.
Dr. A. Sengupta

Click here to go at the top

1

16-10-2015

EDITORIAL BOARD
CHIEF EDITOR
EDITOR
ASSOCIATE EDITOR

DR. ABHIJIT SENGUPTA

MS. JEENATARA BEGUM
MR. DIPANJAN MANDAL

HISTORICAL ARTICLE

Aage Bohr (1922 2009)

Early Life and Education
Aage Niels Bohr was born in Denmarks capital city, Copenhagen, on
June 19, 1922.
In the same year as Aage was born, his father, Niels Bohr, was
awarded the Nobel Prize in Physics for his explanation of the
structure of atoms and the radiation emitted by them.
Aages mother, Margrethe Nrlund, gave birth to six children all
boys; Aage was the fourth. Margrethe was well educated; she
assisted Niels Bohr with his paperwork and discussed his scientific
research with him in detail.
Aage Bohrs education was both conventional and, from a scientific
point of view, extraordinarily privileged. Like many other students of
high school age in Copenhagen, he attended grammar school the
Sortedam Gymnasium. Unlikeother students, he also enjoyed
conversations with some of the worlds most outstanding physicists,
including his father, of course.
In later life Aage recalled some of the giants of science who had
worked in Copenhagen with his father; he met them so regularly that
they became his uncles including Uncle Werner Heisenberg
(Nobel Prize in Physics 1932) and Uncle Wolfgang Pauli (Nobel
Prize in Physics 1945).

Click here to go at the top

2

16-10-2015

Aage Bohrs Scientific Work

Like his father, Aage Bohr was intrigued by the structure of the
atom. The atomic nucleus in particular; that tiny, densely packed,
positively charged mass at the heart of every atom interested him
intensely.
What was the nucleus really like were there any structural
details, and if so, what were they?
The Nucleus as a Drop of Liquid
One idea, which had been developed most fully by Niels Bohr and
John Archibald Wheeler in the late 1930s, was the liquid-drop model.
The liquid-drop model pictured the nucleus as a rotating drop of
incompressible liquid held together by surface tension.
The drop of liquid could be deformed from its basic spherical
shape and a large drop of liquid could fall apart to form two new
drops. Similarly a large atomic nucleus, like uranium, could fall
apart to form two new atomic nuclei this is nuclear fission, the
energy source behind both the uranium atom bomb and the
uranium power plant.
The liquid drop model had its greatest successes in explaining the
properties of heavy nuclei, such as uranium.
By 1950, however, the liquid drop model was in danger of being
pushed aside by the newer shell model of the nucleus.
The Nucleus with Energy Shells
Much like electrons are said to occupy shells of different
energy outside the nucleus, the shell model of the nucleus says
protons and neutrons occupy distinct energy shells inside the
nucleus.
By 1950, most physicists had decided the shell model looked more
promising than the liquid-drop model.
In particular, the shell model explained why atomic nuclei with socalled magic numbers of protons+neutrons are particularly stable.
This is similar to the concept taught in high school chemistry,
where atoms with complete electron shells, for example, 2 or 8
Click here to go at the top
3

16-10-2015

electrons in their outermost shells are particularly stable, leading

to the unreactive behavior of the noble gases.
In the case of atomic nuclei, the magic numbers of 2, 8, 20, 28, 50,
82 and 126 protons+neutrons result in particularly stable nuclei.
The shell model was particularly good at explaining the properties
of lighter nuclei and nuclei with the magic numbers of
protons+neutrons, but was less successful with heavy nuclei such
as uranium.
Unification
In fact, the liquid-drop model and the shell model both had
advantages and disadvantages indicating that neither could be
the full story.
In 1949, James Rainwater, a Columbia University physicist,
decided to combine the best aspects of the liquid-drop and shell
models into a single unified model of the nucleus.
At that time Rainwater shared an office at Columbia with Bohr
and explained his ideas to him. Bohr was captivated, seeing the
potential of Rainwaters ideas to explain the behavior and
structure of the atomic nucleus.
Bohr returned to Copenhagen, determined to pursue the unified
model further. There he worked with Ben Mottelson, who had
completed his Ph.D. at Harvard University and who was now in
Copenhagen on a Traveling Fellowship from Harvard.
Together, Bohr and Mottelson worked out in intricate detail how a
unified model could explain a huge number of experimental
observations from different atomic nuclei. In 1953 they published a
173-page report describing their unified model and in 1954 Bohr
published The Rotational States of Atomic Nuclei. Crucially, predictions
they made about how nuclei would behave were verified in
experiments.
One of their key findings was that some of the behavior of nuclei
could be explained by nuclei having different amounts of energy
resulting from rotation. Furthermore, nuclei do not rotate as rigid
objects but, instead, a surface wave travels around the nucleus.
Click here to go at the top
4

16-10-2015

They also found that nuclei vibrate, changing their shape around
an average value.
At first Bohr had trouble convincing his father that the liquid-drop
model should be dropped after all, Niels Bohr was one of the
liquid-drop models main architects but eventually he won his
father round.
The unified model often called the collective model is sometimes
likened to a swarm of bees, where each bee is a neutron or proton
and the swarm is the nucleus. The swarm acts as a single entity,
even though each bee within it is moving around independently
with its own, individual energy. In the Bohr-Mottelson model, the
outside of the swarm rotates and wobbles inward and outward.
Each neutron or proton has its own orbital energy within the
nucleus. These orbits can sometimes deform the nucleus so that it
is no longer truly spherical. For example, the nucleus of heavier
atoms can become an oblate spheroid (discus shaped) or prolate
spheroid (football shaped).
Of course, we need to remember that atomic nuclei have a
diameter of between 1.7 x 1015 m for hydrogen and about 15 x
1015 m for uranium.
The fact that Bohr and others were able to mathematically model
such incredibly small objects, producing fine structural detail, and
predicting their behavior in agreement with experimental data is
remarkable.
In 1975, Aage Bohr, Ben Mottelson and James Rainwater shared the
Nobel Prize in Physics for their model of the nucleus. In the words
of the award committee, the prize was:
for the discovery of the connection between collective motion and
particle motion in atomic nuclei and the development of the theory
of the structure of the atomic nucleus based on this connection.
Despite the huge strides taken by the trio of physicists, even today,
the structural details of atomic nuclei have still not been fully
resolved.

Click here to go at the top

5

16-10-2015

The End
Aage Bohr died on September 8, 2009, aged 87. He was buried in
the Mariebjerg Cemetery, Copenhagen. His first wife, Marietta,
died in 1978.
Bohr was survived by his second wife, Bente Meyer Scharff, whom
he had married in 1981, and by two sons and a daughter from his
marriage to Marietta. One of his sons, Tomas, became a Professor
of Physics at the Technical University of Denmark.

NEWS UPDATE

For children with rare genetic disorder, more

extensive epilepsy surgery yields better seizure
control: (15th October, 2015)

Children with the genetic disorder tuberous sclerosis complex

(TSC) often need epilepsy surgery for severe, uncontrollable
seizures. A new study finds that seizure control is improved for
patients undergoing more extensive surgery.

Researchers link organ transplant drug to rise in

rare lymphoma: (15th October, 2015)

The immunosuppressive drug mycophenolate mofetil (MMF) has

been linked by a researcher to an increased risk of central nervous
system (CNS) lymphoma in solid organ transplant patients,
suggests a new report.

Developing tools to find new generation

antibiotics: (15th October, 2015)

Scientists have taken an important step in the search to find new

antibiotics that are effective against resistant bacteria. The work,
scientists say, will provide new tools for creating stable genetically
engineered strains which could lead to improvements to existing
antibiotics and the development of new ones.

Click here to go at the top

6

16-10-2015

Study reveals high rates of preventable cancers

in Indigenous peoples of high-income countries:
(15th October, 2015)

New research highlights the scale and profile of cancer in

indigenous peoples of the USA, Canada, Australia and New
Zealand, revealing high rates of often preventable cancers
including lung and cervical cancer, emphasizing the need for
targeted prevention strategies in these populations.

Decoding the microbial signature of aggressive

form of breast cancer: (15th October, 2015)

Researchers have identified, for the first time, an association

between two microbial signatures and triple negative breast
cancer, the most aggressive form of the disease.

Gene signature may help predict survival

outcomes for some children with
rhabdomyosarcoma: (15th October, 2015)

Among children with intermediate-risk rhabdomyosarcoma that is

negative for a fusion gene, those who had a high score of a specific
gene signature called MG5 had poorer survival outcomes
compared with those who had a low score of MG5, report
researchers.

Proteins play key role in genes that help

auditory hair cells grow: (15th October, 2015)

Right now, there is no way to reverse hearing loss, largely because

auditory hair cells, which sense sound and relay that information
to the brain, do not regenerate. A new study, however, has found a
key clue to how these hair cells develop. The study identified a
new role for a particular group of proteins in the development and
survival of the hair cells.

Click here to go at the top

7

16-10-2015

Laser-based imaging tool could increase

accuracy, safety of brain tumor surgery: (14th
October, 2015)

Researchers are testing technology that gives brain surgeons realtime microscopic vision of tumors, potentially allowing the surgical
decision-making process to become data driven, instead of subjective
"best guesses," say authors of a new report.

Four in ten older adults burdened by demands

of health care system: (13th October, 2015)
Nearly four in ten older adults say that managing their health care
needs is difficult for them or their families, that medical
appointments or tests get delayed or dont get done, or that all of
the requirements of their health care are too much to handle, new
research suggests.

Both red and white wine can improve sugar

control depending on genetic profile: (13th
October, 2015)
In this first two year long alcohol study, researchers aimed to
assess the effects and safety of initiating moderate alcohol
consumption in diabetics, and sought to determine whether the
type of wine matters. They gradually initiated moderate wine
consumption, as part of a healthy diet platform, and not before
driving. The trial completed with unprecedented adherence rate of
87 percent after two years.
For detail mail to editor

Click here to go at the top

8

16-10-2015

KNOWLEDGE BASED ARTICLE

FDA expands approved use of Opdivo in advanced

lung cancer

The U.S. Food and Drug Administration today approved Opdivo

(nivolumab) to treat patients with advanced (metastatic) nonsmall cell lung cancer whose disease progressed during or after
platinum-based chemotherapy.
Lung cancer is the leading cause of cancer death in the United
States, with an estimated 221,200 new diagnoses and 158,040
deaths in 2015. The most common type of lung cancer, non-small
cell lung cancer (NSCLC), is further divided into two main
types named for the kinds of cells found in the cancer squamous
cell
and
non-squamous
cell
(which
includes
adenocarcinoma).Opdivo works by targeting the cellular pathway
known as PD-1/PD-L1 (proteins found on the bodys immune cells
and some cancer cells). By blocking this pathway, Opdivo may
help the bodys immune system fight the cancer cells. Earlier this
year, the FDA approved Opdivoto treat patients with
advanced squamous NSCLC whose disease progressed during or
after platinum-based chemotherapy. Todays approval expands the
use of Opdivo to also treat patients with non-squamous NSCLC.
There is still a lot to learn about the PD-1/PD-L1 pathway and its
effects in lung cancer, as well as other tumor types, said Richard
Pazdur, M.D., director of the Office of Hematology and Oncology
Products in the FDAs Center for Drug Evaluation and Research.
While Opdivo showed an overall survival benefit in certain nonsmall cell lung cancer patients, it appears that higher expression of
PD-L1 in a patients tumor predicts those most likely to benefit.
The safety and effectiveness of Opdivo for this use was
demonstrated in an international, open-label, randomized study of
582 participants with advanced NSCLC whose disease progressed
during or after treatment with platinum-based chemotherapy and
appropriate biologic therapy. Participants were treated with
Click here to go at the top
9

10

16-10-2015

Opdivo or docetaxel. The primary endpoint was overall survival,

and the secondary endpoint was objective response rate (the
percentage of patients who experienced complete or partial
shrinkage of their tumors). Those treated with Opdivo lived an
average of 12.2 months compared to 9.4 months in those treated
with docetaxel. Additionally, 19 percent of those treated with
Opdivo experienced a complete or partial shrinkage of their
tumors, an effect that lasted an average of 17 months, compared to
12 percent among those taking docetaxel, which lasted an average
of six months.
While patients who received Opdivo lived longer than those who
received docetaxel across the study, an evaluation of samples from
a subgroup of patients tumors suggests that the level of PD-L1
expression in NSCLC tumors may help identify patients who are
more likely to live longer due to treatment with Opdivo. Therefore,
today the FDA also approved the PD-L1 IHC 28-8 pharmDx test to
detect PD-L1 protein expression levels and help physicians
determine which patients may benefit most from treatment with
Opdivo.
The most common side effects of Opdivo are fatigue,
musculoskeletal pain, decreased appetite, cough and constipation.
Opdivo also has the potential to cause serious side effects that
result from the immune system effect of Opdivo (known as
immune-mediated side effects). These severe immune-mediated
side effects involve healthy organs, including the lung, colon, liver,
kidneys, hormone-producing glands and the brain.
The FDA granted Opdivo breakthrough therapy designation for
this indication based on preliminary clinical evidence that
suggested Opdivo may offer a substantial improvement over
available therapies. It also received priority review status, which is
granted to drugs that, at the time the application was submitted,
have the potential to be a significant improvement in safety or
effectiveness in the treatment of a serious condition. The approval
of Opdivo occurred approximately three months ahead of the
prescription drug user fee goal date of January 2, 2016, the date
Click here to go at the top
10

11

16-10-2015

when the agency was scheduled to complete its review of the

application.
Another drug called Keytruda (pembrolizumab), manufactured by
Merck, also targets the PD-1/PD-L1 pathway and was granted
accelerated approval last weekfor treating NSCLC specifically for
patients whose tumors expressed PD-L1.
Opdivo is marketed by Bristol-Myers Squibb based in Princeton,
New Jersey. ThePD-L1 IHC 28-8 pharmDx test is marketed by
Dako North America Inc. in Carpinteria, California.
The FDA, an agency within the U.S. Department of Health and
Human Services, protects the public health by assuring the safety,
effectiveness, and security of human and veterinary drugs, vaccines
and other biological products for human use, and medical devices.
The agency also is responsible for the safety and security of our
nations food supply, cosmetics, dietary supplements, products
that give off electronic radiation, and for regulating tobacco
products.
Jeenatara Begum
Assistant Professor
GNIPST

DISEASE RELATED BREAKING NEWS

Circulating vaccine-derived poliovirus Lao

Peoples Democratic Republic: (12th October,
2015)

On 8 October 2015, the National IHR Focal Point of the Lao

Peoples Democratic Republic (PDR) notified WHO of one
confirmed type 1 vaccine-derived poliovirus (VDPV) case.
Read more

Click here to go at the top

11

12

16-10-2015

UPCOMING EVENTS

3rd International Conference and Exhibition on Pharmacognosy,

Phytochemistry & Natural Products will be held on 26th to 28th
October, 2015 at Hydrabad.

DRUGS UPDATES

Acetaminophen

Tablets

by

Medline

Industries:

Recall - Mislabeling with Incorrect Strength: (15th

October, 2015)
On October 9, 2015, Medline Industries, Inc. announced that it will
initiate a voluntary nationwide recall of lot # 45810 of
Acetaminophen tablets, 500mg, uncoated compressed tablets to
the consumer level. The Acetaminophen 500mg, Tab 100/BT
(OTC20101) has been found to be mislabeled displaying
Acetaminophen 325mg (OTC10101) instead of Acetaminophen
500mg. The Acetaminophen tablets, 500mg is incorrectly labeled
as 325 mg tablets. This error is not easily identifiable by the user or
prescriber. If the product is taken at the maximum labeled dose,
every four hours, five doses a day, or with other medications
containing acetaminophen, it may lead to liver toxicity or liver
failure.
Read more

CAMPUS NEWS
National Science Day 2015:

On 7th November 2015, GNIPST is going to organize National

Seminer on Current Innovation in Biotechnology for Human
Welfare, a one Day Programme on Science for Nation
Building Sponsored by West Bengal State Council of Science
& Technology, Catalysed & Supported by National Council for
Science, Technology & communication, DST, New Delhi.
Click here to go at the top
12

13

16-10-2015

Name of the committees are given below:

Chief Patron: Sardar Jodh Singh
Patron: Mr Taranjit Singh
Advisor: Mr U. S. Mukherjee Prof Asit Guha
President: Dr Abhijit Sengupta
Convener : Dr Swati Chakraboty
Organizing Committee:
Chairman: Dr Swati Chakraboty
Co-Chairman: Dr Lopamudra Dutta
Organizing Secretary: Dr Asis Bala
Joint Secretary: Dr Prerona Saha
Tresurer: Sumana Roy
Scientific Committee:
Chairman: Dr Sumana Chatterjee
Co-Chairpersons: Debabroto Ghosh Dostidar
Reception & Hospitality Committee:
Chairman: Jaydip Roy
Co-Chairpersons: Sanchari Bhattacharya, Debasruti Ganguly,Dr
Utsav Debnath
Souvinior Committee:
Chairman: Dr Sriparna Kundu Sen
Co-Chairpersons: Jeenatara Begum, Sourav Pal
Registration Committee:
Click here to go at the top
13

14

16-10-2015

Chairman: Samrat Bose

Co-Chairpersons: Prapti Chakraborty, Moumita Chakraborty
Food & Refreshment Committee: Chairman: Dipanjan Mandal
Co-Chairpersons: Soumya Bhattacharya , Tanmay Majumder
Publicity & Invitation Committee: Chairman: Tamalika
Chakraborty
Co-Chairpersons: Dr Aparupa Bhattacharya, Dr Kirat Ganguly, Dr
Bhaskar Choudhuri, Abhishek Chatterjee
Decoration Committee: Chairman: Anuranjita Kundu
Co-Chairpersons: Dr Koushik Sen, Sampat Kundu
Name of the Student members for different Committees are:
B.Pharm 4th year:
Anirban Roy
Subhadeep Das
Aishika Datta
Puja Adhikari
Maitryee Banerjee
Sreya Sanyal
Nilotpal Gorai
Subham Ghoshal
Suprabhat Bhattacharjee
Abhinandan Mondal
Tanmoy Das Biswas
Arijit Mondal
Click here to go at the top
14

15

16-10-2015

Chandrika Saha
Swaranjit Banik
Sourav Saha
B.Sc 1st year:
Meghna Sur
Shivangi Pandey
Shivangi Choudhury
Vaishali Kacchalia
Sonali Thakkur
Simona Basak
Abhishek Chakroborty
Adrija Bhattacharjee
Chandrayee Sil
Somoduity Paul
Rishav Biswas
Solanki Sanu
P.Meghna Rao
Nimisha Choudhury
Indrila Mukherjee
Piu Bhattacharjee
Rudra Sen
Sayantani Guha
Avik Saha
Raj Adhya
Click here to go at the top
15

16

16-10-2015

Sudeshna Chaterjee
Ankan Bhowmik
Ritwika Sur
Debleena Sil
Sayantan Sarkar
Nilanjan Roy
Anamika Ghosh
Srayan Biswas
B.Sc 2nd year:
Ritobroto Paul
Soumik Majumder
Sikha Jain
Varsha Srivastab
Riyanka Majumder
Protim Singha Roy
Nilabja Seel
Vishal Kumar Singh
Ankita Aditya
B.Sc 3rd year:
Imtiaz Mahamud
Bipasha Ray
Ankita Roy
Camellia Roy
Sreejita Roy
Click here to go at the top
16

17

16-10-2015

BHM 1st year:

Mayuri Ghosh
Debottri Das
Sunanda Sarkar
BHM 2nd year:
Debashruti Roy
Srikant Kumar
BHM 3rd year:
Subham Chakraborty
Satabdi Bhattacharya

For the National Seminar on Current Innovation in

Biotechnology for Human Welfare on 7th November 2015, last
date for Abstract submission for poster presentation is 28th
October 2015.

Winners of Intracollege Football Tournament:

Congratulations to B.Pharm final year for their victory in

Intracollege Football Tournament.

Intracollege Football Tournament:

On 9th October and 10th October, 2015 GNIPST has organized the
Intracollege Football Tournament.
EN BIOLET:
On 5th and 6th October, 2015 seminar was held on EN-BIOLET by
Stone India Ltd.

Click here to go at the top

17

18

16-10-2015

INDOOR BATTLE 2015

On 24th September, 2015 GNIPST organised the Indoor games

(Table Tennis, Carrom, Chess for both Boys and Girls) Indoor
Battle 2015.
Congratulations to all winners and participants.
The Winners are:

Table Tennis (for Boys):

1st: Soumen Dhara (M.Pharm, 2nd year [Pharmacology])
2nd: Ratul Banduri (B.Pharm, 3rd year)
3rd: Sneham Sen (B.Pharm, 3rd year)
Table Tennis (for Girls):
1st: Sweta Saha (B.Sc [BT], 3rd year)
2nd: Moutan Roy (B.Pharm, 2nd year)
Carrom (for Boys):
1st: Sk. Sajjat Ali (B.Pharm, 4th year) and Sk. Abdul Aslam
(B.Pharm, 3rd year)
2nd: Sourabh Saha (B.Pharm, 4th year) and Rajib Singha Roy
(B.Pharm, 4th year)
3rd: Arnab Banerjee (M.Pharm, 2nd year [Pharmaceutics])
and Achinta Banerjee (M.Pharm, 2nd year [Pharmaceutics])
Carrom (for Girls):
1st: Sreyashee Mitra (B.Pharm 4th year) and Rituparna Das
(B.Pharm 4th year)
2nd: Rinita DasBhowmik (B.H.M, 1st year) and Tania Datta (B.H.M,
1st year)
3rd: Sushmita Sen (D.Pharm, 2nd year) and Keya Das (D.Pharm, 2nd
year)
Chess (for Boys):
1st: Sayantan Dutta (B.Pharm, 3rd year)
2nd: Tanmoy Das Biswas (B.Pharm 4th year)
3rd: Sourabh Saha (B.Pharm 4th year)
Click here to go at the top
18

19

16-10-2015

Chess (for Girls):

1st: Rituparna Das (B.Pharm 4th year)
2nd: Suchetana Dutta (B.Pharm 4th year)
3rd: Krishnakali Basu (B.Pharm 4th year)
SAGAR DUTTA MEDICAL COLLEGE FEST-ASTERICA 2015
WINNER:
The students of GNIPST stood first in the FASHION SHOW
competition of Sagar Dutta Medical College Fest:
Congratulation to the participantsSouvik Ganguly (B.H.M 2nd year)
Riya Taran (B.Pharm 4th year)
Moktar Hossain (B.Pharm 4th year)
Chandrika Saha (B.Pharm 4th year)
Swaranjeet Banik (B.Pharm 4th year)
Sampita Pal (B.Pharm 3rd year)
Ranit Kundu (M.Pharm 1st year)
Susmita Kar (B.Pharm 2nd year)
Md. Nadeem Shah (B.Pharm 4th year)
Sreyashee Mitra (B.Pharm 4th year)
Sunanda (M.Pharm 1st year)
Best Male Model of ASTERICA 2k15:
Souvik Ganguly (B.H.M 2nd year)
Best Female Model of ASTERICA 2k15:
Sampita Pal (B.Pharm 3rd year)
Anchor:
Sreejita Roy (B.Sc )
Solo Singing competition:
Sayantan Goswami (B.Pharm 4th year):winner
Arpita (B.Sc) :2nd runner up
CARNIVAL OF CANVASS:
On 4th September the Students of GNIPST celebrated the freshers
party for Masters degree students.
On 4th September the students of GNIPST celebrated Teachers
Day.
Click here to go at the top
19

20

16-10-2015

ESPERANZA:

On 21st August, 2015 the 1st year students of GNIPST were

welcomed in the Freshers Welcome Programme ESPERANZA.
HOMAGE TO FORMER PRESIDENT DR A P J ABDUL
KALAM:
On 31st July, 2015 all the students and teachers of GNIPST paid
their homage for our former president Dr. A P J Abdul Kalam.
ALUMNI ASSOCIATION:
GNIPST has been certified by the Alumni Association under the
West Bengal Societies Registration Act, 1961.
FAREWELL PROGRAMME:
On 15th May 2015 GNIPST celebrated the farewell programme
Sesh Chithi for the final year students of M.Pharm, M.Sc,
B.Pharm, B.Sc and BHM.
JIS SAMMAN 2015
On 11th May, 2015 GNIPST attended the JIS SAMMAN 2015.
JIS SAMMAN Awards:
Best College (Non Engineering):
GNIPST
Best Principal:
Dr (Prof.) Avijit Sengupta
Best HOD:
Mr. Jaydip Ray
Best Faculty:
Mr. Debabrata Ghoshdastidar (Pharmacy)
Dr. Swati Chakraborty (Life Sciences)
Best faculty since inception:
Mr. Jaydip Ray
Best Office Staff:
Ms. Jaya Banerjee
Best technical Assistant:
Mr. Somnath Majhi
Click here to go at the top
20

21

16-10-2015

College Blue:
Avik Paul
Highest DGPA of 2014:
B.Pharm:
Purbali Chakraborty (4th year)
Diksha Kumari (3rd year)
Aishika Dutta (2nd year)
Sampita Paul (1st year)
M.Pharm:
Aritra Mukherjee (Pharmaceutical Chemistry)
Mounomukhar Bhattacharya (Pharmacology)
B.Sc (Biotechnology):
Papiya Saha (3rd year)
Shomasree Das (2nd year)
Ayanita Basak (1st year)
B.Sc (Microbiology):
Bonhisikha Chatterjee (3rd year)
Riaz Hossain (2nd year)
Soumi Chowdhury (1st year)
BHM:
Bishal Roy (3rd year)
Shreyabhanja Chowdhury (2nd year)
Recitation:
Udita Majumder
Debate:
Srijita Roy
Poushali Ganguly
Quiz:
Arani
Dipayan Nath
Band:
Syantan Ghoswami
Anurag Ghosh

Ray

Click here to go at the top

21

22

16-10-2015

Atanu Mondal
Arka Khamaru
Ritobroto Paul
Abhirup Dasgupta
Fashion:
Md. Nadeem Shah
Koustav Sarkar
Shaksar Saha
Avirup Dasgupta
Ranit Kundu
Namrata Ganguly
Shreyasee Mitra
Chandrika Saha
Debopriya Chatterjee
Riya Taran
Innovative Modeling:
Ankit Chowdhury
Kartik Koley
Mudasar Manna
Dipan Chaterjee
Abhishek Singh
Kaustav Pal
Manojit Dutta
SPIRIT JIS 2015
On 03th to 05th April, 2015 JIS organised SPIRIT JIS 2015.
GPAT 2015 Result:
The following B.Pharm. final year students have qualified, GPAT2015. We congratulate them all.
Diksha Kumari
Rupanjay Bhattacharya
Avik Paul
Xtasy 2015:
GNIPST is going to organize the Tech Fest Xtasy 2015 from 30th
March, 2015 to 1st April, 2015.
Click here to go at the top
22

23

16-10-2015

FINISHING SCHOOL TRAINING PROGRAMME:

The FINISHING SCHOOL TRAINING PROGRAMME was

organized by the Entrepreneurship Development Cell and Training
& Placement Cell, GNIPST in collaboration with Indian Pharmacy
Graduates Association (IPGA), Bengal Branch from 21st February
to 11th April, 2015 at GNIPST Auditorium.
st
On 21 February, 2015 the Finishing School Training Programme of
GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy
Director, Drug Control Office, Goutam Kr. Sen, President, IPGA,
Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr.
Ranendra Chakraborty, Sales Manager and Associate Director Dr.
Reddys Laboratory.
On 28th February, 2015 Dr. D. Roy, Former Deputy Drug
Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager,
Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning &
Development, Cipla delivered their valuable lectures in the 2nd day
FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.
On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager,
QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager,
Operation, Ranbaxy Laboratory Limited delivered their valuable
lectures in the 3rd day FINISHING SCHOOL TRAINING
PROGRAMME of GNIPST.
On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President
(Quality Assurance), Albert David Ltd. delivered his valuable
lectures in the 4th FINISHING SCHOOL TRAINING
PROGRAMME of GNIPST.
On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of Jadavpur
University and presently associated with NIPER delivered his
valuable lectures in the 5th FINISHING SCHOOL TRAINING
PROGRAMME of GNIPST.
On 11th April, 2015 the closing ceremony of the FINISHING
SCHOOL TRAINING PROGRAMME was held in GNIPST
Auditorium.
Click here to go at the top
23

24

16-10-2015

JOBS:

All the students of Final Year B. Pharm and M. Pharm are hereby
informed that an interview will be conducted on 23rd May, 2015 by
Standard Pharmaceuticals Ltd. GSK for post: Production, QA, QC.
All the students of Final Year B. Pharm and M. Pharm are hereby
informed that an interview will be conducted by GSK for sales and
marketing job.
Details given below:
Date: 27.03.2015
Time: 09:45 am
Venue : GSK Consumer Healthcare Limited, Unit No. 208,
nd
2 Floor, Ecospace Campus B (3 B), New Town,
Rajarhat, 24 Pgs (N). Kolkata-700156.
THYROCARE provisionally selected 15 students from JIS Group.
Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc
Biotechnology have been selected.
Ipsita Mondal (M. Sc Biotechnology)
Debriti Paul (M. Sc Biotechnology)
Debopriya Chatterjee {B. Sc (H) Biotechnology}
The final year students of B.Pharm (31 students) and B.Sc (11
students) attended the pooled campus drive of Abbott India Ltd.
on 10th March, 2015 at Jadavpur University. Among them 17
students have gone through to the final round of this pooled
campus drive and short listed for final selection.
ACHIEVEMENT:
Congratulations to Anurag Chanda, student of B.Pharm final year
who have got the 1st prize in poster presentation event in Prakriti
2015 at Department of Agricultural and Food engineering, IIT,
Kharagpur.
OTHERS:
On 24th and 25th February, 2015 Swamiji of Gourio Math was
delivered some motivational lectuers in GNIPST.
The students of GNIPST participated in the 4th Sardar Jodh
th
SinghTrophy organised by NIT on 20 February, 2015.
Click here to go at the top
24

25

16-10-2015

On 8th February, 2015 Gnipst celebrated the Reunion

programmeReminiscence Reloaded 2015.

STUDENTS SECTION
WHO CAN ANS WER FIRS T????
Answer of Previous Issues Questions:
Artemisinin

Identify the person

Answer of Previous Issues Image:

Tu Youyou and Lou Zhicen

Send

your
thoughts/
Quiz/Puzzles/games/write-ups or any other
contributions for Students Section& answers
of this Section at gnipstbulletin@gmail.com
EDITORS NOTE
It is a great pleasure for me to publish the 1st issue of 50th Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
are able to avail the bulletin through facebook account GNIPST
bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
Click here to go at the top
25

26

16-10-2015

of GNIPST for his valuable advice and encouragement. Special

thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the
improvement of the bulletin is the contribution of the readers. You
are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.

ARCHIVE
The general body meeting of APTI, Bengal Branch has been
conducted at GNIPST on 15th June, 2012. The program started with
a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural
Products, JU on the skill to write a good manuscript for
publication in impact journals. It was followed by nearly two hour
long discussion among more than thirty participants on different
aspects of pharmacy education. Five nonmember participants
applied for membership on that very day.
GNIPST is now approved by AICTE and affiliated to WBUT for
conducting the two years post graduate course (M.Pharm)
in PHARMACOLOGY. The approved number of seat is 18.
The number of seats in B.Pharm. has been increased from 60 to
120.
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
Click here to go at the top
26

27

16-10-2015

d. Approved duration: 3 years

e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.

Activity Clubs of GNIPST:

Name of Club
SPORTS
LITERARY AND PAINTING
SCIENCE AND INNOVATIVE
MODELLING
ECO
SOCIAL SERVICES
PHOTOGRAPHY
CULTURAL
DEBATE AND EXTEMPORE

Member Faculty
Mr. Debabrata GhoshDastidar
Ms. Jeenatara Begum
Mr. Samrat Bose
Ms. Sumana Roy
Dr. Asis Bala
Ms. Sanchari Bhattacharya
Ms. Priyanka Ray
Mr. Soumya Bhattacharya

Click here to go at the top

27